Sanofi Consumer Healthcare India Ltd - Stock Valuation and Financial Performance

BSE: 544250 | NSE: SANOFICONR | Pharmaceuticals & Drugs |

Sanofi Cons. Health Share Price

4,938.90 0.00 0.00%
as on 25-Apr'25 16:59

DeciZen - make an informed investing decision on Sanofi Cons. Health

Overall Rating
Login to view analysis. Bole Toh

1. Quality


Login to view analysis.

2. Valuation


Login to view analysis.

3. Price Trend


Login to view analysis.

Sanofi Consumer Healthcare India stock performance -

P/E Ratio (SA):
62.84
Market Cap:
11,374.6 Cr.
52-wk low:
4,360.3
52-wk high:
5,499

Is Sanofi Consumer Healthcare India Ltd an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of Sanofi Cons. Health: Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Sanofi Consumer Healthcare India Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Dec'23Dec'24TTM
ROCE % 105.6%104.3%-
Value Creation
Index
6.86.7-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 555725725
Sales YoY Gr.-30.5%-
Adj EPS 830.887.278.6
YoY Gr.--89.5%-
BVPS (₹) 923118.3118.1
Adj Net
Profit
166201181
Cash Flow from Ops. -0.4439-
Debt/CF from Ops. 00-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NANANA30.5%
Adj EPS NANANA-89.5%
BVPSNANANA-87.2%
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Dec'23Dec'24TTM
Return on
Equity %
8083.666.5
Op. Profit
Mgn %
39.437.438.7
Net Profit
Mgn %
29.927.725
Debt to
Equity
000
Working Cap
Days
012689
Cash Conv.
Cycle
0-1858

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Sanofi Consumer Healthcare India Ltd.

Standalone Consolidated
TTM EPS (₹) 78.6 -
TTM Sales (₹ Cr.) 725 -
BVPS (₹.) 118.1 -
Reserves (₹ Cr.) 249 -
P/BV 41.81 -
PE 62.84 -
From the Market
52 Week Low / High (₹) 4360.30 / 5499.00
All Time Low / High (₹) 4360.30 / 5499.00
Market Cap (₹ Cr.) 11,375
Equity (₹ Cr.) 23
Face Value (₹) 10
Industry PE 39.3

Quarterly Results

 Mar'24 YoY Gr. Rt. %Jun'24 YoY Gr. Rt. %Sep'24 YoY Gr. Rt. %Dec'24 YoY Gr. Rt. %
Sales (₹ Cr.) 292 10.7293 12.4344 9.9319 11.4
Adj EPS (₹) 2.3 N/A1.4 928.61.8 863.23.3 513.2
Op. Profit Mgn % 24.02 952 bps25.16 674 bps25.02 575 bps25.27 217 bps
Net Profit Mgn % 6.98 958 bps6.01 492 bps5.33 422 bps9.85 784 bps

Management X-Ray of Sanofi Cons. Health:

Shareholding Pattern

JavaScript chart by amCharts 3.21.5
JavaScript chart by amCharts 3.21.5Promoters:60.4%Institutions:29.43%Non-Institutions:10.17%

Promoter's Holding & Share Pledging

JavaScript chart by amCharts 3.21.5Sep24Dec24Mar250%10%20%30%40%50%60%70%
Pledged *0.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Sanofi Cons. Health

MRP
spaceLock icon
MOS
spaceLock icon%
DP
spaceLock icon
Base EPS
spaceLock icon
DPS
spaceLock icon
MRP: ₹ 0
DP: ₹0
Base EPS ₹:
DPS ₹:
MOS (%):
Expected EPS Growth Rate:
0%
Base 0%
50%
Expected Rate of Return:
0%
Base 0%
50%
Future PE:
0
Base 0
200
YTD 1Y 3Y 5Y 10Y Max
YTD 1Y 3Y 5Y 10Y Max
YTD 1Y 3Y 5Y 10Y Max
YTD 1Y 3Y 5Y 10Y Max

Event Update

Login/Register to view analysis.

Analyst's Notes

No data found!

Key Ratios of Sanofi Cons. Health

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Company Name CMP(₹)
Change ₹(%)
Market Cap
Net Sales (₹ Cr.)
Latest EPS (₹)
Net Profit Margin %
Latest P/E
Latest P/BV
Sun Pharma Inds. 1,812 25.2 (1.4%) Large Cap 48,497 47.7 20.9 37.5 6
Dr. Reddys Lab 1,196 22.5 (1.9%) Large Cap 28,011 64.4 19.6 18.2 3.1
Cipla 1,547.2 21.7 (1.4%) Large Cap 25,774 61.8 15.6 24.7 4.1
Lupin 2,086.9 68.6 (3.4%) Mid Cap 20,011 62.8 9.7 32.1 5.6
Zydus Lifesciences 875.3 16.2 (1.9%) Large Cap 19,547 45.1 19.3 19.1 3.8
Glenmark Pharma 1,387 28.1 (2.1%) Mid Cap 11,813 -6.2 -10.2 - 4.4
Torrent Pharma 3,304.7 68.7 (2.1%) Large Cap 10,728 55 14.8 58.8 13.7
Aurobindo Pharma 1,226.4 8.5 (0.7%) Mid Cap 10,646 33 17.2 36.9 3.5
Alkem Laboratories 5,085.7 49.9 (1%) Mid Cap 9,748 190.9 18.1 26.4 4.8
Mankind Pharma 2,581.8 30.1 (1.2%) Mid Cap 9,265 47.4 19.6 53.8 7.4
Shows rows:

Profit And Loss

(All Figures are in Crores.)
PARTICULARSDec'23Dec'24
Sales555725
Operating Expenses 337454
Manufacturing Costs4345
Material Costs152186
Employee Cost 54103
Other Costs 87120
Operating Profit 219271
Operating Profit Margin (%) 39.4%37.3%
Other Income 413
Interest 04
Depreciation 25
Exceptional Items -2-28
Profit Before Tax 219247
Tax 5466
Profit After Tax 165181
PAT Margin (%) 29.7%25.0%
Adjusted EPS (₹)824.578.7
Dividend Payout Ratio (%)6%70%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSDec'23Dec'24

Equity and Liabilities

Shareholders Fund 185272
Share Capital 223
Reserves 183249
Minority Interest00
Debt00
Long Term Debt00
Short Term Debt00
Trade Payables6070
Others Liabilities 99204
Total Liabilities 344547

Fixed Assets

Gross Block1140
Accumulated Depreciation611
Net Fixed Assets529
CWIP 31
Investments 00
Inventories9741
Trade Receivables3214
Cash Equivalents 2327
Others Assets206135
Total Assets 344547

Cash Flow

(All Figures are in Crores.)
PARTICULARSDec'23Dec'24
Cash Flow From Operating Activity 0439
PBT 219247
Adjustment -21
Changes in Working Capital -213316
Tax Paid -4-124
Cash Flow From Investing Activity 02
Capex -4-10
Net Investments 00
Others 412
Cash Flow From Financing Activity 2-116
Net Proceeds from Shares 20
Net Proceeds from Borrowing 00
Interest Paid 00
Dividend Paid 0-115
Others 00
Net Cash Flow 2325
PARTICULARSDec'23Dec'24
Ratios
ROE (%)89.3379.28
ROCE (%)105.64104.33
Asset Turnover Ratio1.681.7
PAT to CFO Conversion(x)02.43
Working Capital Days
Receivable Days2011
Inventory Days6133
Payable Days144128

Sanofi Consumer Healthcare India Ltd Stock News

Sanofi Consumer Healthcare India Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Sanofi Cons. Health on 25-Apr-2025 16:59 is ₹4,938.9.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 25-Apr-2025 16:59 the market cap of Sanofi Cons. Health stood at ₹11,374.6.
The latest P/E ratio of Sanofi Cons. Health as of 25-Apr-2025 16:59 is 62.84.
The latest P/B ratio of Sanofi Cons. Health as of 25-Apr-2025 16:59 is 41.81.
The 52-week high of Sanofi Cons. Health is ₹5,499 and the 52-week low is ₹4,360.3.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Sanofi Cons. Health is ₹724.5 ( Cr.) .

About Sanofi Consumer Healthcare India Ltd

No data to display
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...